Evaluating HPLC, UHPLC, and UPLC System Performance Using a Reversed-Phase Method for Peptides

Significance of the Topic

Modern liquid chromatography platforms with reduced system dispersion enhance the analysis of complex biomolecules. Minimizing extra-column band broadening improves resolution and peak capacity, which is critical for reliably separating closely eluting peptide and protein fragments in pharmaceutical development and quality control.

Objectives and Study Overview

This study compares the performance of three LC platforms—traditional HPLC, UHPLC, and UPLC—using a reversed-phase peptide method. The primary goals were to quantify extra-column band broadening and to evaluate resolution and peak capacity under identical gradient conditions across the three systems.

Methodology and Instrumentation

• A zero-dead-volume union replaced the analytical column to measure extra-column dispersion. A 1 μL caffeine injection in 30:70 water:acetonitrile was run isocratically at 0.3 mL/min to determine band broadening.
• A reversed-phase gradient assay (5–50% acetonitrile in TFA over 10 minutes) was performed on a Waters XBridge BEH C18 column (130 Å, 2.5 μm, 4.6 × 100 mm).
• Three systems evaluated:
  • Alliance HPLC
  • Arc Bio UHPLC
  • H-Class Bio UPLC
• Data processing, peak width, and resolution calculations followed USP guidelines using Empower 3.

Major Findings and Discussion

• Extra-column band broadening decreased from 50 μL (HPLC) to 23 μL (UHPLC) and 7 μL (UPLC).
• Resolution between critical peptide peaks improved from 1.7 (HPLC) to 2.7 (UHPLC) and 3.1 (UPLC).
• Peak capacity increased from 118 (HPLC) to 170 (UHPLC) and 196 (UPLC).

These improvements are attributed to reduced physical dispersion in lower-dispersion systems, enabling narrower peaks and greater separation efficiency.

Benefits and Practical Applications

• Enhanced separation of closely eluting biomolecules and peptides.
• Increased sensitivity and peak capacity benefit QC and research labs.
• Seamless transfer of existing HPLC methods to advanced platforms.
• Enables use of smaller particles and narrower columns without exceeding pressure limits.

Future Trends and Potential Applications

• Integration with sub-2 μm particle columns and high-pressure systems for ultra-high-resolution separations.
• Application in proteomics and complex biotherapeutic analyses.
• High-throughput method development for continuous manufacturing and process analytical technology.
• Broader regulatory acceptance of advanced LC platforms in pharmaceutical quality assurance.

Conclusion

Transitioning from HPLC to UHPLC and UPLC systems significantly reduces extra-column band broadening, leading to sharper peaks, higher resolution, and increased peak capacity. These performance gains support more reliable analyses of peptides and biotherapeutics, offering a clear pathway for modernizing legacy methods and improving laboratory throughput and data quality.